Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 20.28 | 20.26 |
PEG Ratio (TTM) | 2.71 | 3.42 |
P/S Ratio (TTM) | 0.40 | 0.45 |
P/B Ratio (TTM) | 1.34 | 4.17 |
P/FCF Ratio (TTM) | 25.35 | 17.64 |
Price to 5YR AVG Earnings Ratio | 18.00 | 22.34 |
Price to 5YR AVG FCF Ratio | 19.56 | 23.17 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.54% | 4.61% |
ROE (TTM) | 6.75% | 21.55% |
Net Profit Margin (TTM) | 1.97% | 1.77% |
ROIC 5YR AVG | 10.49% | 13.58% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -4.20% | 24.97% | 14.55% |
Revenue | 0.10% | 6.59% | 6.19% |
Net Income | -4.41% | 24.94% | 14.55% |
Cash Flow | 78.13% | 19.85% | 9.55% |
Health (84%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.62 | 0.98 |
Quick Ratio (TTM) | 1.69 | 0.47 |
D/E Ratio (TTM) | 0.13 | 1.69 |
Interest Coverage (TTM) | 10.29 | 12.54 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 5.63 | 4.04 |
LTL to 5YR AVG FCF | 1.47 | 6.26 |
Shares Outstanding Growth 5YR AVG | N/A | 2.25% |